Skip to main content
letter
. 2020 May 12;9(3):407–416. doi: 10.1007/s40121-020-00301-w

Table 1.

Expert position on the strengths and weaknesses of soluble urokinase plasminogen activator receptor (suPAR) for the prognosis of patients at the emergency department (ED)

Reference Strengths
[10] Concentrations > 6 ng/ml have high sensitivity for unfavourable outcome and signify considerable risk of death for patients admitted to the ED
[11] Concentrations < 4 ng/ml have high NPV for unfavourable outcome and allow discharge of the patient from the ED
[14] Concentrations < 12 ng/ml for patients with infections and systemic inflammatory response syndrome have high NPV for unfavourable outcome after 28 days
Reference Limitations
[1] Non-specific for certain disease entities
[36] Comorbidities such as chronic renal disease, HIV infection, solid tumour malignancy increase baseline levels
[10] Concentrations between 4 and 6 ng/ml do not clearly indicate the risk of unfavourable outcome for patients admitted to the ED

HIV human immunodeficiency virus, NPV negative predictive value